Ivo Caers

Janssen (Switzerland) — Switzerland

Medicine · Health Sciences

9h-index468citations14works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(5), Hormonal and reproductive studies(3), Prostate Cancer Treatment and Research(2), Health Systems, Economic Evaluations, Quality of Life(2), Treatment of Major Depression(2)

Publications14 total

P.2.h.016 Interleukin-6 antibody Sirukumab improves depressive symptoms in a randomized, placebo-controlled, phase 2 study in patients with rheumatoid arthritis
European Neuropsychopharmacology·2015· 1 cited
P.2.b.033 Siltuximab improves depressive symptoms in a randomised, placebo-controlled, phase 2 study in patients with multicentric Castlemen's disease
European Neuropsychopharmacology·2015
SAT0182 Improvement in Measures of Depressed Mood and Anhedonia, and Fatigue, In a Randomized, Placebo-Controlled, Phase 2 Study of Sirukumab, A Human Anti-Interleukin-6 Antibody, In Patients with Rheumatoid Arthritis
Annals of the Rheumatic Diseases·2015· 16 cited
Determinants of Antipsychotic Response in Schizophrenia
The Journal of Clinical Psychiatry·2014· 84 cited
Combining efficacy and completion rates with no data imputation: A composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials
European Neuropsychopharmacology·2013· 2 citedOpen Access
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Schizophrenia Research·2013· 52 cited
Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences
Schizophrenia Research·2013· 76 cited
P.3.a.012 Age of onset of schizophrenia and outcomes in 29 placebo-controlled RCT's of antipsychotics in the NEWMEDS repository
European Neuropsychopharmacology·2011
Age of onset of schizophrenia and outcomes in 29 placebo-controlled RCT's of antipsychotics in the NEWMEDS repository
UCL Discovery (University College London)·2011
Risperidone in the Treatment of Psychosis of Alzheimer Disease: Results From a Prospective Clinical Trial
American Journal of Geriatric Psychiatry·2006· 93 cited
Effects of high-dose ketoconazole and dexamethasone on ACTH-stimulated adrenal steroidogenesis in orchiectomized prostatic cancer patients
European Journal of Endocrinology·1987· 16 cited
EFFECTS OF HIGH DOSE KETOCONAZOLE THERAPY ON THE MAIN PLASMA TESTICULAR AND ADRENAL STEROIDS IN PREVIOUSLY UNTREATED PROSTATIC CANCER PATIENTS
Clinical Endocrinology·1986· 67 cited
Ketoconazole: From an antimycotic to a drug for prostate cancer
Drug Development Research·1986· 26 cited
Effect of a single administration of ketoconazole on total and physiologically free plasma testosterone and 17β-oestradiol levels in healthy male volunteers
European Journal of Clinical Pharmacology·1985· 35 cited

Frequent Co-authors

Jonathan Rabinowitz(5), Nomi Werbeloff(5), Shitij Kapur(5), Virginia L. Stauffer(4), Bruce J. Kinon(4), R. De Coster(4), Francine S. Mandel(3), François Ménard(3), Willem K. Amery(3), C. Haelterman(3), Giacomo Salvadore(3), M C Coene(2), D. Beerens(2), Benjamin Hsu(2), Jaskaran Singh(2), Michael A. Curran(2), Gayle Wittenberg(2), G. Chen(2), D. Wang(2), Jacobo Mintzer(1)